Stocky turns companies like innoscripta SE I into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for innoscripta SE I:
Quality + moat + leadership + valuation fused into a single 0–100 number. When you see a Verdict/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
innoscripta SE I is under analysis by Stocky. Once the full Verdict is calculated, this page updates automatically with a 0–100 score, band (Buy / Hold / Avoid), and the specific thesis.
The Stocky Verdict for 1INN.DE is being computed. It's a 0–100 composite score built from the Compounder Score (business quality), Moat Score, Leadership Alignment and valuation vs peers.
Stocky hasn't finalised a Moat Score for innoscripta SE I yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Leadership Alignment for innoscripta SE I is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.
Vulnerability Profile for innoscripta SE I covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.
Sign up free and unlock the full analysis on 1INN.DE — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for 1INN.DE in the app.
